Structural basis of RNA cap modification by SARS-CoV-2

The Storage and In-Use Stability of mRNA Vaccines and Therapeutics: Not A Cold Case - Journal of Pharmaceutical Sciences

Structural biology of SARS-CoV-2: open the door for novel therapies

Structural biology of SARS-CoV-2 and implications for therapeutic development

Enzymatic Assays to Explore Viral mRNA Capping Machinery - Kasprzyk - 2021 - ChemBioChem - Wiley Online Library

Coronavirus Disguises Its mRNAs Using a Cap-Modifying Enzyme

PDF] Structural basis for m7G recognition and 2′-O-methyl discrimination in capped RNAs by the innate immune receptor RIG-I

Frontiers The regulation of antiviral innate immunity through non-m6A RNA modifications

Mn2+ coordinates Cap-0-RNA to align substrates for efficient 2′-O-methyl transfer by SARS-CoV-2 nsp16

Frontiers SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development

Chan Lab

PDB-101: Molecule of the Month: SARS-CoV-2 RNA-dependent RNA Polymerase

Structural basis of RNA cap modification by SARS-CoV-2

In Vitro Reconstitution of SARS-Coronavirus mRNA Cap Methylation

Two Years into the COVID-19 Pandemic: Lessons Learned

SARS-CoV-2 nsp16 Methyltransferase (2019-nCoV nsp16, 2'-O-MTase, ME, nsp16, 2'-O-methyltransferase, SARS-CoV-2 nsp16, SARS-CoV-2 nsp16, Severe Acute Respiratory Syndrome Coronavirus 2 nsp16 Methyltransferase)